Skip to main content

Advertisement

Log in

Which way for genetic-test regulation? Leave test interpretation to specialists

  • Opinion
  • Published:

From Nature

View current issue Submit your manuscript

An Opinion to this article was published on 11 August 2010

Although largely unregulated, genetic tests are increasingly used to diagnose conditions, map ancestry or predict disease risk. In this, the first of two related pieces, Arthur L. Beaudet advocates the US Food and Drug Administration banning direct-to-consumer medical tests but leaving the analysis of clinical diagnostics to specialists. In the second, Gail Javitt argues that the agency should implement a regulatory framework for all health-related tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

Arthur L. Beaudet is in the Department of Molecular and Human Genetics at Baylor College of Medicine, which receives revenue from offering genetic laboratory testing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beaudet, A. Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 466, 816–817 (2010). https://doi.org/10.1038/466816a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/466816a

  • Springer Nature Limited

This article is cited by

Navigation